Ibuprofene Arrow Lab (Ibuprofen)

Ibuprofen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, ibuprofen reduces the sensitisation of pain receptors, lowers the hypothalamic set‑point for body temperature, and diminishes the inflammatory response.

The appropriate dose of Ibuprofene Arrow Lab is set by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Dosage may differ for pain, fever, or inflammatory disorders, and the prescriber will consider any relevant medical history before recommending a regimen.

Ibuprofen is generally avoided in the third trimester of pregnancy because it may affect fetal cardiovascular development. Use during the first two trimesters should only occur if the potential benefit outweighs the risk and under medical advice. Limited data exist for breastfeeding, so a clinician should evaluate safety before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ibuprofene Arrow Lab. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibuprofen and naproxen belong to the same NSAID class and share similar mechanisms of COX inhibition. Ibuprofen has a shorter half‑life, often requiring multiple daily doses, whereas naproxen provides longer‑lasting relief with fewer doses. Both carry comparable gastrointestinal and cardiovascular risks, but individual tolerance and specific clinical scenarios guide the choice.

Ibuprofene Arrow Lab should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, light and excessive heat, and ensure they are out of reach of children.

The product is intended for oral administration. Tablets are swallowed whole with a full glass of water, preferably with food or milk to minimise gastrointestinal irritation. The exact dosing schedule and duration are determined by the prescribing clinician.

Serious adverse events include gastrointestinal bleeding or ulceration, severe renal impairment, hepatotoxicity, and hypersensitivity reactions such as anaphylaxis. Cardiovascular risks, such as increased blood pressure or thrombotic events, may also occur, especially with high‑dose or prolonged therapy.

Individuals with a known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulceration or bleeding, severe renal or hepatic impairment, and patients in the third trimester of pregnancy should avoid this medication. Caution is also advised for patients with uncontrolled hypertension or significant cardiovascular disease.